EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app

Carmen Martín-Sierra, Mavys Tabraue Chavez, Pablo Escobedo, Victor García-Cabrera, Francisco Javier López-Delgado, Juan Jose Guardia-Monteagudo, Isidoro Ruiz-García, Miguel M Erenas, Rosario Maria Sanchez-Martin, Luis Fermín Capitán-Vallvey, Alberto J Palma, Salvatore Pernagallo und 1 weitere

Biosensors and Bioelectronics · 2023

DOI: 10.1016/j.bios.2023.115268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023. Verfasst von Carmen Martín-Sierra und 12 weiteren Autor:innen. Beteiligte Einrichtung: DESTINA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Avenida de la Innovación 1, Edificio BIC, 18016, Armilla, Granada, Spain; GENYO …. Hauptthemen laut MEDLINE: COVID-19, Mobile Applications, Biosensing Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has highlighted the need for innovative approaches to its diagnosis. Here we present CoVradar, a novel and simple colorimetric method that combines nucleic acid analysis with dynamic chemical labeling (DCL) technology and the Spin-Tube device to detect SARS-CoV-2 RNA in saliva samples. The assay includes a fragmentation step to increase the number of RNA templates for analysis, using abasic peptide nucleic acid probes (DGL probes) immobilized to nylon membranes in a specific dot pattern to capture RNA fragments. Duplexes are formed by labeling complementary RNA fragments with biotinylated SMART bases, which act as templates for DCL. Signals are generated by recognizing biotin with streptavidin alkaline phosphatase and incubating with a chromogenic substrate to produce a blue precipitate. CoVradar results are analysed by CoVreader, a smartphone-based image processing system that can display and interpret the blotch pattern. CoVradar and CoVreader provide a unique molecular assay capable of detecting SARS-CoV-2 viral RNA without the need for extraction, preamplification, or pre-labeling steps, offering advantages in terms of time (∼3 h/test), cost (∼€1/test manufacturing cost) and simplicity (does not require large equipment). This solution is also promising for developing assays for other infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Mobile ApplicationsBiosensing TechniquesHumansSARS-CoV-2RNA, ViralPandemicsSmartphoneNucleic Acid Amplification Techniques

Stichwörter der Autor:innen

Colourimetric assayCoronavirus disease 19 (COVID-19)Dynamic chemistry labelling (DCL)Image processing system (IPS)Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2)

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • DESTINA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Avenida de la Innovación 1, Edificio BIC, 18016, Armilla, Granada, Spain; GENYO Centre for Genomics and Oncological Research, Pfizer/University of Gra…
  • DESTINA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Avenida de la Innovación 1, Edificio BIC, 18016, Armilla, Granada, Spain.
  • ECsens, CITIC-UGR, Department of Electronics and Computer Technology, University of Granada, 18071, Granada, Spain; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada…
  • ECsens, Department of Analytical Chemistry, University of Granada, 18071, Granada, Spain; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, Granada, Spain.
  • GENYO Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada - Avenida de la Ilustración, 114- 18016, Granada, Spain; Department of Medicinal & Organic Che…
  • DESTINA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Avenida de la Innovación 1, Edificio BIC, 18016, Armilla, Granada, Spain. Electronic address: salvatore.pernagallo@destinagenomics.com.

Zitieren

APA

Martín-Sierra, C., Chavez, M. T., Escobedo, P., García-Cabrera, V., López-Delgado, F. J., Guardia-Monteagudo, J. J., Ruiz-García, I., Erenas, M. M., Sanchez-Martin, R. M., Capitán-Vallvey, L. F., Palma, A. J., Pernagallo, S., & Diaz-Mochon, J. J. (2023). SARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115268

Vancouver

Martín-Sierra C, Chavez MT, Escobedo P, García-Cabrera V, López-Delgado FJ, Guardia-Monteagudo JJ, et al. SARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app. Biosensors and Bioelectronics. 2023. doi:10.1016/j.bios.2023.115268

BibTeX
@article{MartnSierra2023,
  author = {Martín-Sierra, Carmen and Chavez, Mavys Tabraue and Escobedo, Pablo and García-Cabrera, Victor and López-Delgado, Francisco Javier and Guardia-Monteagudo, Juan Jose and Ruiz-García, Isidoro and Erenas, Miguel M and Sanchez-Martin, Rosario Maria and Capitán-Vallvey, Luis Fermín and Palma, Alberto J and Pernagallo, Salvatore and Diaz-Mochon, Juan Jose},
  title = {SARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app},
  journal = {Biosensors and Bioelectronics},
  year = {2023},
  doi = {10.1016/j.bios.2023.115268}
}
Kostenlos starten →